GeneDx Holdings Corp. (WGS)
82.00
+2.53
(+3.18%)
USD |
NASDAQ |
Mar 05, 16:00
84.06
+2.06
(+2.51%)
After-Hours: 20:00
GeneDx Holdings Cash from Investing (Quarterly) : -11.07M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Illumina, Inc. | 108.00M |
| Guardant Health, Inc. | -905.07M |
| Quest Diagnostics, Inc. | -191.00M |
| Labcorp Holdings, Inc. | -389.90M |
| Natera, Inc. | -71.59M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.09M |
| Cash from Financing (Quarterly) | 23.19M |
| Free Cash Flow | 14.26M |
| Free Cash Flow Per Share (Quarterly) | -0.256 |
| Free Cash Flow to Equity (Quarterly) | -6.215M |
| Free Cash Flow to Firm (Quarterly) | -6.933M |
| Free Cash Flow Yield | 0.60% |